— Know what they know.
Not Investment Advice

APLT NASDAQ

Applied Therapeutics, Inc.
1W: -13.6% 1M: -58.5% 3M: -85.7% 1Y: -88.3% 3Y: -87.5% 5Y: -99.6%
$0.10
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $14.9M mcap · 120M float · 13.18% daily turnover · Short 35% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
+573.9% YoY
$-18M
Net Income
+90.3% YoY
$-87M
Free Cash Flow
-6.1% YoY
100.0%
Gross Margin
-1675.8%
Op. Margin
-1899.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-680.5%
ROA-25.7%
ROIC776.9%

Valuation

P/E-0.4
P/B-26.7
EV/EBITDA-0.8

Leverage

Debt/Equity-4.46
Current Ratio0.96
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z-34.08
Beneish M18.98

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms